Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2013 it was 100.0%, against 100.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 100.0% | +0.0 |
| FY2012 | Dec 31, 2012 | 100.0% | +0.0 |
| FY2011 | Dec 31, 2011 | 100.0% | +0.0 |
| FY2010 | Dec 31, 2010 | 100.0% | – |
See a number that looks wrong?